CompletedPhase 1NCT00789568
A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects
Studying Classic phenylketonuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- BioMarin Pharmaceutical
- Principal Investigator
- Don Nwose, MD, M.DBioMarin Pharmaceutical
- Intervention
- sapropterin dihydrochloride(drug)
- Enrollment
- 56 enrolled
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2008 – 2009
Study locations (1)
- PRACS Institute, Ltd., Fargo, North Dakota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00789568 on ClinicalTrials.govOther trials for Classic phenylketonuria
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07241234A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With PhenylketonuriaAgios Pharmaceuticals, Inc.
- RECRUITINGNANCT07526909Effect of Different Meal Types Given Before Exercise on Plasma Amino Acid Levels and Metabolic Control Parameters in Classical Phenylketonuria Patients Undergoing Aerobic and Resistance ExercisesHacettepe University
- ACTIVE NOT RECRUITINGPHASE4NCT06780332Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to PalynziqBioMarin Pharmaceutical
- RECRUITINGNANCT01659749Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With PhenylketonuriaEmory University